GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Investments And Advances

Seneca Biopharma (STU:7NS2) Investments And Advances : €0.00 Mil (As of Dec. 2020)


View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma Investments And Advances?

Seneca Biopharma's Investments And Advances for the quarter that ended in Dec. 2020 was €0.00 Mil.


Seneca Biopharma Investments And Advances Historical Data

The historical data trend for Seneca Biopharma's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma Investments And Advances Chart

Seneca Biopharma Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Seneca Biopharma Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Seneca Biopharma Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Seneca Biopharma (STU:7NS2) Business Description

Traded in Other Exchanges
N/A
Address
20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876
Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines